Literature DB >> 2388482

Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.

M Eder1, O G Ottmann, T E Hansen-Hagge, C R Bartram, S Gillis, D Hoelzer, A Ganser.   

Abstract

We investigated the effects of interleukin-7 (IL-7), a stromal cell derived cytokine known to stimulate proliferation of murine lymphoid precursor cells, alone and in combination with IL-3, IL-1, and IL-6 on proliferation of purified blast cells in acute lymphoblastic leukemia (ALL). After 7 days of liquid culture DNA-synthesis was induced in six of 10 cALL, three of five B-ALL, and two of seven T-ALL samples by IL-7 or IL-3 or both. Monitoring of leukemic cell populations in suspension culture by Southern blot analysis of immunoglobulin and T cell receptor gene rearrangements revealed preferential stimulation of the leukemic cell clone by both IL-7 or IL-3 in one cALL and one B-ALL sample. In these cases the combination of IL-7, IL-3, and IL-1 was as effective in stimulation of DNA-synthesis as the most potent cytokine alone. There was no evidence of lymphoid maturation during liquid culture as defined by immunophenotyping using flow cytometry. Stimulation of nonleukemic cell population seen in two other cases of cALL was associated with residual erythroid and granulocyte-macrophage colony forming cells after liquid culture as defined in parallel clonogenic assays in one and detection of CD 33+ and CD 13+ cells after culture in the other cALL sample. We conclude that IL-7 directly stimulates monoclonal growth of leukemic cells in a subset of ALL without evidence of concurrent maturation induction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388482

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.

Authors:  Sara González-García; Marta Mosquera; Patricia Fuentes; Tiziana Palumbo; Adela Escudero; Antonio Pérez-Martínez; Manuel Ramírez; Anne E Corcoran; Maria L Toribio
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

2.  Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells.

Authors:  R Yoshioka; S Shimizu; J Tachibana; Y Hirose; M Fukutoku; Y Takeuchi; S Sugai; T Takiguchi; S Konda
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

3.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Potential implications of interleukin-7 in chronic wound healing.

Authors:  Annie Bartlett; Andrew J Sanders; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Exp Ther Med       Date:  2016-04-18       Impact factor: 2.447

Review 5.  IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.

Authors:  Mariana L Oliveira; Padma Akkapeddi; Daniel Ribeiro; Alice Melão; João T Barata
Journal:  Adv Biol Regul       Date:  2018-09-19

Review 6.  Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.

Authors:  Fátima Bayón-Calderón; María L Toribio; Sara González-García
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.